Major pharmacy retailers pull heartburn medication Zantac from shelves after FDA detects carcinogens in samples of drug

Wilfredo Lee/AP

• Walgreens, CVS, and Rite Aid announced they are pulling the heartburn medication Zantac and other generic versions from their shelves, citing reports from the Food and Drug Administration of a cancer-causing contaminant in samples of the drug earlier this month.
• The FDA detected low levels of nitrosodimethylamine (NDMA), which is a type of nitrosamine, in samples of the heartburn drug. Nitrosamines can increase a person's risk for cancer and are believed to be carcinogenic to humans.
• While major pharmacy retailers are pulling the heartburn medication from their shelves, the companies that make the drug — including Sanofi, which makes brand-name Zantac — have yet to recall it.
• Visit Business Insider's homepage for more stories.

Walgreens, CVS, and Rite Aid announced they are pulling the heartburn medication Zantac and other generic versions from their shelves, citing reports from the Food and Drug Administration of a cancer-causing contaminant in samples of the drug earlier this month.

The FDA detected low levels of nitrosodimethylamine (NDMA), which is a type of nitrosamine, in samples of the heartburn drug, which is also known as ranitidine.

See the rest of the story at Business Insider

NOW WATCH: Subway's 42,000 locations are the most of any fast-food chain on the planet, but franchise owners are taking a hit

See Also:

• Costco workers reveal 33 things they'd love to tell shoppers, but can't
• I'm a financial planner — here's the single best piece of advice I can give you about money
• McDonald's employees share the 4 menu items they'd never eat

SEE ALSO: FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity

from Feedburner https://ift.tt/2nZNo1I
via IFTTT